MEDIPEEL Appoints Jason Wi as CEO to Drive Global Operational Excellence and Strategic Growth
On February 26, 2026, MEDIPEEL, a leading name in the K-beauty industry and majority-owned by Morgan Stanley Private Equity Asia, made headlines by appointing Jason Wi as its new Chief Executive Officer. Wi, a seasoned expert in global operations and partnerships, is expected to spearhead a comprehensive restructuring of MEDIPEEL's global operations to build a resilient and scalable operational model aimed at sustainable international growth.
Wi brings with him extensive experience from his tenure at McKinsey & Company and SoftBank Ventures Asia, where he honed his skills in strategic consulting and investments. His career is characterized by proven successes in expanding rapidly growing platforms and leading various businesses in the Korean clinical skincare sector. MEDIPEEL aims to leverage Wi's deep expertise and global network to accelerate its transformation into a dominant player in the global cosmetics market.
The company is shifting focus from a traditional export-centric model to a localized partnership-based approach. This transformation aims to create a more structured and flexible operational system while reinforcing its core identity as an "efficacy-driven derma beauty brand," ensuring competitiveness in advanced international markets. With Morgan Stanley PE’s support and Wi’s operational acumen, MEDIPEEL is poised to establish a sustainable framework that can adapt to volatile market conditions.
Furthermore, Wi plans to incorporate data-driven operational methodologies, which have been fine-tuned during his experience in the platform industry, into MEDIPEEL's core operations. Key initiatives include optimizing supply chain management and enhancing customer engagement to achieve long-term operational efficiency and profitability. "The sustainable success of K-beauty brands on the global stage relies on two key pillars: a strong brand heritage and an institutionalized operational system that can uphold it," stated CEO Jason Wi. "We will focus on bolstering strategic global alliances while elevating our internal standards to transform MEDIPEEL into a trusted world-class beauty platform."
MEDIPEEL is the flagship brand under SKINIDEA, part of MDP Holdings, associated with Morgan Stanley PE Asia. Known for its innovative products that marry premium ingredients with patented dermatological technology, SKINIDEA exports to over 75 countries, developing highly effective skincare solutions based on comprehensive research and clinical studies, ensuring both immediate and long-term improvements tailored to various skin types. WI's appointment heralds a new chapter for MEDIPEEL as it looks to expand its footprint and solidify its market position amidst an ever-evolving beauty landscape.
Wi brings with him extensive experience from his tenure at McKinsey & Company and SoftBank Ventures Asia, where he honed his skills in strategic consulting and investments. His career is characterized by proven successes in expanding rapidly growing platforms and leading various businesses in the Korean clinical skincare sector. MEDIPEEL aims to leverage Wi's deep expertise and global network to accelerate its transformation into a dominant player in the global cosmetics market.
The company is shifting focus from a traditional export-centric model to a localized partnership-based approach. This transformation aims to create a more structured and flexible operational system while reinforcing its core identity as an "efficacy-driven derma beauty brand," ensuring competitiveness in advanced international markets. With Morgan Stanley PE’s support and Wi’s operational acumen, MEDIPEEL is poised to establish a sustainable framework that can adapt to volatile market conditions.
Furthermore, Wi plans to incorporate data-driven operational methodologies, which have been fine-tuned during his experience in the platform industry, into MEDIPEEL's core operations. Key initiatives include optimizing supply chain management and enhancing customer engagement to achieve long-term operational efficiency and profitability. "The sustainable success of K-beauty brands on the global stage relies on two key pillars: a strong brand heritage and an institutionalized operational system that can uphold it," stated CEO Jason Wi. "We will focus on bolstering strategic global alliances while elevating our internal standards to transform MEDIPEEL into a trusted world-class beauty platform."
MEDIPEEL is the flagship brand under SKINIDEA, part of MDP Holdings, associated with Morgan Stanley PE Asia. Known for its innovative products that marry premium ingredients with patented dermatological technology, SKINIDEA exports to over 75 countries, developing highly effective skincare solutions based on comprehensive research and clinical studies, ensuring both immediate and long-term improvements tailored to various skin types. WI's appointment heralds a new chapter for MEDIPEEL as it looks to expand its footprint and solidify its market position amidst an ever-evolving beauty landscape.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.